These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1790443)

  • 21. Effect of plasmapheresis in active systemic lupus erythematosus.
    Kater L; Derksen RH; Houwert DA; Hené RJ; Struyvenberg A; Gmelig Meyling FH; Verroust P
    Neth J Med; 1981; 24(6):209-16. PubMed ID: 7322246
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies of genetic polymorphism of complement C2, B and C6 in systemic lupus erythematosus].
    Yukiyama Y; Tokunaga K; Yoshida K; Miyamoto T
    Ryumachi; 1985 Sep; 25(4):274-7. PubMed ID: 4081907
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunological criteria in the diagnosis of systemic lupus erythematosus].
    Shaposhnikov OK; Gorbunov VF
    Vestn Dermatol Venerol; 1984 May; (5):4-8. PubMed ID: 6204467
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lupus erythematosus disseminatus. (Apropos of a review of 49 cases)].
    Dutschmann L; Ferreira C; Pinto MF; Bordalo e Sá O; Ribeiro M; da Costa N
    Acta Med Port; 1984; 5(9-10):263-70. PubMed ID: 6524449
    [No Abstract]   [Full Text] [Related]  

  • 25. [Detection of leukocyte and platelet antibodies in systemic lupus erythematosus and related syndromes].
    Mayer S; Souissi T; Tongio MM; Berrebi A
    Nouv Rev Fr Hematol; 1971; 11(5):701-16. PubMed ID: 4114387
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
    Blum C; Zillikens D; Tony HP; Hartmann AA; Burg G
    Hautarzt; 1993 May; 44(5):290-5. PubMed ID: 8320115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinico-immunologic characteristics of patients with systemic lupus erythematosus living in a hot climate].
    Rasulov UR
    Ter Arkh; 1989; 61(5):121-5. PubMed ID: 2528835
    [No Abstract]   [Full Text] [Related]  

  • 29. Variability of the lupus band test. Results in 18 patients with systemic lupus erythematosus.
    Jacobs MI; Schned ES; Bystryn JC
    Arch Dermatol; 1983 Nov; 119(11):883-9. PubMed ID: 6357104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reticuloendothelial system Fc receptor function in the drug induced lupus erythematosus syndrome.
    Fields TR; Zarrabi MH; Gerardi EN; Bennett RS; Zucker S; Hamburger MI
    J Rheumatol; 1986 Aug; 13(4):726-31. PubMed ID: 3772920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between organic changes, antibodies against native DNA and antinuclear antibody titer in patients with systemic lupus erythematosus].
    Marczak M; Kardaszewicz E
    Pol Tyg Lek; 1985 Jun; 40(23):654-6. PubMed ID: 3876550
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnostic value of the immunofluorescence method in lupus erythematosus].
    Fülöp E; Vajda Z; Kühn G
    Dermatol Monatsschr; 1974 Jun; 160(6):474-82. PubMed ID: 4603472
    [No Abstract]   [Full Text] [Related]  

  • 33. [Solubility of immune complexes and activity of the alternative complement pathway in patients with systemic lupus erythematosus].
    Riera Cervantes N; Geffner J; Isturiz MA; Manni JA; de Bracco MM
    Rev Clin Esp; 1985 Oct; 177(6):254-7. PubMed ID: 4081196
    [No Abstract]   [Full Text] [Related]  

  • 34. Procainamide-induced systemic lupus erythematosus.
    Rutherford BD
    N Z Med J; 1968 Oct; 68(437):235-40. PubMed ID: 5247682
    [No Abstract]   [Full Text] [Related]  

  • 35. [Blast transformation reaction in systemic lupus erythematosus].
    Lenchivi ; Sura VV
    Vestn Akad Med Nauk SSSR; 1970; 25(9):16-9. PubMed ID: 5492394
    [No Abstract]   [Full Text] [Related]  

  • 36. [Course and prognosis of systemic lupus erythematosus. Evaluation based on the analysis of 41 own observations].
    Vachtenheim J
    Cas Lek Cesk; 1967 Aug; 106(34):924-9. PubMed ID: 5584207
    [No Abstract]   [Full Text] [Related]  

  • 37. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Le cells in the "skin window" in patients with systemic lupus erythematosus].
    Kozlovskaia LV; Tareeva IE; Tuganbekova SK; Ianushkevich TN
    Ter Arkh; 1988; 60(7):88-90. PubMed ID: 2463694
    [No Abstract]   [Full Text] [Related]  

  • 39. Two days of internal medicine "systemic lupus erythematosus".
    Lipsmeyer EA
    J Ark Med Soc; 1980 Sep; 77(4):165-7. PubMed ID: 6447684
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acute lupus erythematosus induced by procainamide].
    Manigand G; Foulon D; Perrigot M; Deparis M
    Sem Hop; 1973 Nov; 49(48):3207-10. PubMed ID: 4364913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.